Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Down almost 30% on less than $600 traded today. Holiday hangover?
I said maybe. 50% increase does mean something even in future.
There's zero volume today. So, takeover? Nobody buying this?
Today due to price action. No news,yet.
Feb. 13,2024 said maybe a buy is coming. Well today,maybe. lar
Due diligence can be a bit*h
Thanks. There have been several "close but no cigar" events.
Just the scuttlebutt in Boca. VYCO asked price is now .13.
What makes you think the takeover is finally coming?
New surgical instruments. Brain and vertebral investigation and surgery with minimal tissue sensitivy.
Good question. Like rubbing sticks in the rain to start a fire. That's the heat lol
Who is taking over?
Going to get hot,hot.
I guess there's no one here anymore.
Is this even trading anymore? No volume for over a week.....
Wonderful "Mark"$$ for a prize of a higher calling...… NY, Y hasn't the news moved shareholders to action 2020 see more clearly A Smart.32 possible if they push NOW
thanks just gave you a member mark
Brilliant$$ ...… Similar profile interests "seek and ye shall find".. ALMY
Chill to blazing.. U Moderate .25 we r truth
.32 +90%
VYCO
Giddy Up. Time to Hammer down....GO VYCO .25
Glad to have paid forward.... Is there a Twitter Account here Go $$VYCO
Had to reset Princess, they have brought Royalty onboard and your continued support would be appreciated. Go $VYCO pennies to quarters.
Chinga, This beauty has been silent for 60 days your last post. On this post the results are shown. Witness the birth of Royal 2. The story is now to be told.... Royal ======>>>
VYPH. HPD/CBD Come forth VYCO .25
Yup no action... slowly dumping 1.5 billion shares then reverse split again.
Vycor Medical's NovaVision Launches its European Internet-Delivered Therapy Suite at the 3rd European Conference of NeuroRehabilitation
VYCO
http://www.otcmarkets.com/stock/VYCO/news/Vycor-Medical-s-NovaVision-Launches-its-European-Internet-Delivered-Therapy-Suite-at-the-3rd-European-Conference-of-NeuroRehabilitation?id=120279&b=y
They have employees, revenue, and cash.
Worth at least $1.25.
Got some in the 60s. Time to close the gap.
Unless these guys do a JV/licensing, this will be a horrible investment in the near-term. Many micro caps like this one go BK when they are the sole funders of very aggressive plans…on multiple product lines. They need the JV(s). I do not know if Management has their egos where their good sense should be instead. I think we'll see by end of summer. In the meantime, they do not have the capital to even produce the hardware for the hospitals, etc. I am concerned about dilution if they don't go the JV route. I also wonder why they can't break into the VA system for their units. That would be a Home Run.
Impressive video.
https://vimeo.com/39766887
Adding to Watch List at The Biotech Stock Review.
http://biotechstockreview.ning.com/profiles/blogs/adding-vycor-medical-inc-vyco-1-15-to-watch-list
Also impressive..
http://www.fhcpartners.com/
http://www.fhcpartners.com/fhcpartners/the_team.php
Under the terms of the exchange, the Fountainhead Parties will receive $2,355,587 of Vycor Series D preferred shares ("Series D") that will be convertible into Vycor Shares at a price of $2.15. The Series D will carry a dividend of 7% per annum, payable in cash or Series D at the Company's option. The Company is able to redeem the Series D at par at any time, at its sole option. The Fountainhead Parties will also receive 3-year warrants equivalent to 75% of the Vycor Shares received in the exchange on a converted basis, exercisable at $3.08. Full details will be contained in a Form 8-K filing.
Adrian Liddell, the chairman of Vycor, commented: "This transaction was carefully reviewed by outside counsel and based on their expertise the Audit Committee and Board of Directors of Vycor consider this exchange as very beneficial to the Company, considerably strengthening the balance sheet, and in the best interests of all shareholders."
At the same time, in a transaction not related to the exchange, Fountainhead entered into an agreement with the Company preventing it from selling any Vycor Shares currently held by Fountainhead below $4.50. In return, the Company agreed to extend the life of certain of Fountainhead's existing warrants expiring in 2015 to the same 3-year term as the warrants being issued under the exchange.
I see Vycor is attempting to re-start their previous failed P&D effort, with a one-day promo that ended at 2pm. LLOLLOLLOL good luck with THAT!! What a JOKE!!
I can see why there are no links to any financial filings!
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10705408
Green heading into power hour!
VYCO
Short Covering gonna happen to $VYCO soon! Look at the short data
$VYCO Short Selling Data Report
http://otcshortreport.com/index.php?index=VYCO#.VNrd5un6MXv
$VYCO on alert, ready to run! http://www.otcmarkets.com/stock/VYCO/profile
BOCA RATON, Fla., June 25, 2015 /PRNewswire/ -- Vycor Medical, Inc. ("Vycor") (OTCQB—VYCO), a provider of innovative and superior surgical and therapeutic solutions, announced the commercial release of its Internet-delivered therapy suite in the U.S. This therapy suite, consisting of its lead Vision Restoration Therapy (VRT) and its NeuroEyeCoach eye-movement compensation therapy, is delivered directly to patients over the Internet onto their own computers replacing the Company's current "prototype hardware centric" model.
To learn more about VYCO visit these web sites
For the latest information on the company, including media and other coverage, and to learn more, please go online at:
http://www.vycormedical.com
http://www.vycorvbas.com
http://www.novavision.com.
Oversold at these levels, bottom in here fast.money
VYCO